Le Lézard
Classified in: Health, Business
Subject: LIC

Beecken Petty O'Keefe & Company Announces Definitive Agreement To Sell Paragon Medical


CHICAGO, April 3, 2018 /PRNewswire/ -- Beecken Petty O'Keefe & Company ("BPOC"), a leading Chicago-based private equity firm focused exclusively on the healthcare industry, announced today that it has entered into a definitive agreement to sell PMG Intermediate Holding Corporation, the parent company of Paragon Medical, Inc., to NN, Inc. (NASDAQ: NNBR), a diversified industrial company based in Johnson City, Tennessee.  The transaction is expected to close in the second quarter of 2018 and is subject to customary closing conditions and regulatory approval. 

Headquartered in Pierceton, Indiana, Paragon Medical creates partnerships with its customers by providing premier engineering, manufacturing, and logistics services from concept of a project to commercialization.  With facilities throughout the United States, Asia, and Europe, Paragon Medical is viewed as a model of excellence for its ability to meet the critical demands of a dynamic medical device global market. 

BPOC partnered with Paragon Medical in 2013, with a vision of building upon Paragon's long history of strong customer relationships and reputation for manufacturing high-quality products.  Tobias "Toby" Buck, Paragon's founder, President and CEO, commented: "We are proud of what we have accomplished over the last several years and grateful for our relationship with BPOC.  Our teams have worked side-by-side in the true spirit of partnership to build upon Paragon's great foundation.  We sincerely appreciate all of BPOC's support, resources and guidance." 

"It's been a privilege to partner with Paragon Medical over the past five years and support the Company in its pursuit of multiple growth strategies, including investments in improved manufacturing, expansion of its global footprint, and increased infrastructure development," said Dave Cooney, Managing Director of BPOC. "We are proud to have worked with the entire Paragon management team through an important phase of growth and wish them success in their next chapter of growth with their new partner, NN, Inc."

William Blair & Company is acting as the financial advisor to Paragon, and Paul Hastings is serving as the legal advisor. 

About Beecken Petty O'Keefe & Company
Beecken Petty O'Keefe & Company is a Chicago-based private equity management firm founded in 1996 to invest in middle-market buy-out transactions, recapitalizations, and growth platforms in the healthcare industry. BPOC has structured, managed and realized investments on behalf of institutional and individual investors for over two decades.  Since inception, BPOC has raised four funds with aggregate capital commitments of over $1.4 billion.

 

SOURCE Beecken Petty O'Keefe & Co.


These press releases may also interest you

at 02:57
For Q1 2024, NORDEN reports a profit of USD 62 million (approx. DKK 435 million). Free cash flow in the first quarter amounted to USD -50 million (approx. DKK -350 million). Return on invested capital (ROIC) was 26% by end of Q1 based on the last...

at 02:45
ASE Technology Holding Co., Ltd. (TWSE: 3711, NYSE: ASX) ("We", "ASEH", or the "Company"), the leading provider of semiconductor assembly and testing services ("ATM") and the provider of electronic manufacturing services ("EMS"), today reported its...

at 02:39
MYTILINEOS Energy & Metals (RIC: MYTr.AT) (Bloomberg: MYTIL.GA) announces its Q1 2024 financial results. 10% increase in Net Profit after minorities to ?158 million vs. ?143 million in Q1 2023. Earnings per Share came in at ?1.141, an increase of...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:26
Having consistently outperformed its targets and strategic goals, MYTILINEOS Energy & Metals ("MYTILINEOS") has initiated a review and evaluation of its strategic options, in consultation with its financial, legal and tax...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: